27420101|t|Bacterial Suppression of RNA Polymerase II - Dependent Host Gene Expression
27420101|a|Asymptomatic bacteriuria (ABU) is a bacterial carrier state in the urinary tract that resembles commensalism at other mucosal sites. ABU strains often lack the virulence factors that characterize uropathogenic Escherichia coli (E. coli) strains and therefore elicit weak innate immune responses in the urinary tract. In addition, ABU strains are active modifiers of the host environment, which they influence by suppressing RNA polymerase II (Pol II)- dependent host gene expression. In patients inoculated with the ABU strain E. coli 83972, gene expression was markedly reduced after 24 h (>60% of all regulated genes). Specific repressors and activators of Pol II - dependent transcription were modified, and Pol II Serine 2 phosphorylation was significantly inhibited, indicating reduced activity of the polymerase. This active inhibition included disease -associated innate immune response pathways, defined by TLR4, IRF-3 and IRF-7, suggesting that ABU strains persist in human hosts by active suppression of the antibacterial defense. In a search for the mechanism of inhibition, we compared the whole genome sequences of E. coli 83972 and the uropathogenic strain E. coli CFT073. In addition to the known loss of virulence genes, we observed that the ABU strain has acquired several phages and identified the lytic Prophage 3 as a candidate Pol II inhibitor. Intact phage particles were released by ABU during in vitro growth in human urine. To address if Prophage 3 affects Pol II activity, we constructed a Prophage 3 negative deletion mutant in E. coli 83972 and compared the effect on Pol II phosphorylation between the mutant and the E. coli 83972 wild type (WT) strains. No difference was detected, suggesting that the Pol II inhibitor is not encoded by the phage. The review summarizes the evidence that the ABU strain E. coli 83972 modifies host gene expression by inhibition of Pol II phosphorylation, and discusses the ability of ABU strains to actively create an environment that enhances their persistence.
27420101	25	42	RNA Polymerase II	T103	UMLS:C0035679
27420101	60	75	Gene Expression	T038	UMLS:C0017262
27420101	76	100	Asymptomatic bacteriuria	T038	UMLS:C0262380
27420101	102	105	ABU	T038	UMLS:C0262380
27420101	143	156	urinary tract	T017	UMLS:C0042027
27420101	194	201	mucosal	T017	UMLS:C0026724
27420101	202	207	sites	T082	UMLS:C0205145
27420101	209	212	ABU	T038	UMLS:C0262380
27420101	236	253	virulence factors	T103	UMLS:C1136170
27420101	272	320	uropathogenic Escherichia coli (E. coli) strains	T007	UMLS:C2717874
27420101	378	391	urinary tract	T017	UMLS:C0042027
27420101	406	409	ABU	T038	UMLS:C0262380
27420101	451	462	environment	T082	UMLS:C0014406
27420101	500	517	RNA polymerase II	T103	UMLS:C0035679
27420101	519	525	Pol II	T103	UMLS:C0035679
27420101	543	558	gene expression	T038	UMLS:C0017262
27420101	592	595	ABU	T038	UMLS:C0262380
27420101	603	616	E. coli 83972	T007	UMLS:C0014834
27420101	618	633	gene expression	T038	UMLS:C0017262
27420101	689	694	genes	T017	UMLS:C0017337
27420101	706	716	repressors	T103	UMLS:C0574031
27420101	721	731	activators	T103	UMLS:C0751968
27420101	735	741	Pol II	T103	UMLS:C0035679
27420101	754	767	transcription	T038	UMLS:C0040649
27420101	787	818	Pol II Serine 2 phosphorylation	T038	UMLS:C2754824
27420101	867	875	activity	T038	UMLS:C0243102
27420101	883	893	polymerase	T103	UMLS:C0035679
27420101	927	934	disease	T038	UMLS:C0012634
27420101	970	978	pathways	T038	UMLS:C1704259
27420101	991	995	TLR4	T103	UMLS:C1321919
27420101	997	1002	IRF-3	T103	UMLS:C0384768
27420101	1007	1012	IRF-7	T103	UMLS:C1530281
27420101	1030	1033	ABU	T038	UMLS:C0262380
27420101	1053	1058	human	T204	UMLS:C0086418
27420101	1094	1115	antibacterial defense	T038	UMLS:C0020964
27420101	1178	1200	whole genome sequences	T017	UMLS:C0017428
27420101	1204	1217	E. coli 83972	T007	UMLS:C0014834
27420101	1226	1261	uropathogenic strain E. coli CFT073	T007	UMLS:C2717874
27420101	1296	1305	virulence	T038	UMLS:C0042765
27420101	1306	1311	genes	T017	UMLS:C0017337
27420101	1334	1337	ABU	T038	UMLS:C0262380
27420101	1366	1372	phages	T005	UMLS:C0004651
27420101	1392	1408	lytic Prophage 3	T005	UMLS:C1136253
27420101	1424	1430	Pol II	T103	UMLS:C0035679
27420101	1449	1454	phage	T005	UMLS:C0004651
27420101	1482	1485	ABU	T038	UMLS:C0262380
27420101	1512	1517	human	T204	UMLS:C0086418
27420101	1518	1523	urine	T031	UMLS:C0042036
27420101	1539	1549	Prophage 3	T005	UMLS:C1136253
27420101	1558	1564	Pol II	T103	UMLS:C0035679
27420101	1565	1573	activity	T038	UMLS:C0243102
27420101	1592	1602	Prophage 3	T005	UMLS:C1136253
27420101	1612	1627	deletion mutant	T038	UMLS:C1511760
27420101	1631	1644	E. coli 83972	T007	UMLS:C0014834
27420101	1672	1694	Pol II phosphorylation	T038	UMLS:C2754824
27420101	1707	1713	mutant	T017	UMLS:C0678941
27420101	1722	1735	E. coli 83972	T007	UMLS:C0014834
27420101	1736	1745	wild type	T017	UMLS:C1883559
27420101	1747	1749	WT	T017	UMLS:C1883559
27420101	1808	1814	Pol II	T103	UMLS:C0035679
27420101	1847	1852	phage	T005	UMLS:C0004651
27420101	1898	1901	ABU	T038	UMLS:C0262380
27420101	1909	1922	E. coli 83972	T007	UMLS:C0014834
27420101	1937	1952	gene expression	T038	UMLS:C0017262
27420101	1970	1992	Pol II phosphorylation	T038	UMLS:C2754824
27420101	2023	2026	ABU	T038	UMLS:C0262380
27420101	2057	2068	environment	T082	UMLS:C0014406
27420101	2089	2100	persistence	T038	UMLS:C0546816